-
Something wrong with this record ?
Effect of n-3 fatty acids supplementation during life style modification in women with overweight
P. Sedláček, I. Plavinová, J. Langmajerová, J. Dvořáková, J. Novák, L. Trefil, L. Müller, P. Buňatová, V. Zeman, D. Müllerová
Language English Country Czech Republic
Document type Journal Article, Randomized Controlled Trial
Digital library NLK
Source
NLK
Free Medical Journals
from 2004
ProQuest Central
from 2009-03-01 to 6 months ago
Medline Complete (EBSCOhost)
from 2006-03-01 to 6 months ago
Nursing & Allied Health Database (ProQuest)
from 2009-03-01 to 6 months ago
Health & Medicine (ProQuest)
from 2009-03-01 to 6 months ago
Public Health Database (ProQuest)
from 2009-03-01 to 6 months ago
ROAD: Directory of Open Access Scholarly Resources
from 1993
PubMed
30660136
DOI
10.21101/cejph.a5259
Knihovny.cz E-resources
- MeSH
- Eicosapentaenoic Acid therapeutic use MeSH
- Docosahexaenoic Acids therapeutic use MeSH
- Humans MeSH
- Overweight therapy MeSH
- Dietary Supplements * MeSH
- Treatment Outcome MeSH
- Healthy Lifestyle * MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
OBJECTIVE: The marine n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exert numerous beneficial effects on health, but their potency to defend against development of peripheral insulin resistance of healthy person with overweight remains poorly characterized. We aimed to evaluate the effect of a combination intervention using EPA + DHA and the lifestyle modification (LSM) in women with overweight. METHOD: In a parallel-group, three-arm, randomized trial (UMIN Clinical Trials Registry - R000031131), 34 women were assigned to a 12-week-intervention using corn oil (1.5 g/day; placebo); LSM and corn oil (1.5 g/day; LSM); or LSM and EPA + DHA concentrate (1.5 g/day, containing ~ 0.6 g EPA + DHA; LSM & n-3). At baseline and after intervention, anthropometric measurements including bioelectrical impedance analysis, spiroergometry, 24-hours dietary recall, and various metabolic markers, adiponectin and cytokines were evaluated in serum using standard procedures. Data from 29 women were used for the final evaluation. Wilcoxon two-sided rank-sum test was used to inspect the differences between LSM and LSM & n-3, and placebo groups, with a p-value of ≤ 0.05. All computations were performed with MATLAB Statistics Toolbox. RESULTS: In comparison with placebo, LSM and LSM & n-3 decreased body weight, waist circumference, and body fat, and increased VO2max/kg. LSM & n-3 increased adiponectin levels in comparison to LSM. Fasting insulin, IL8, and cholesterol were decreased by LSM, but were unchanged by LSM & n-3. IL6 was not affected in LSM & n-3, while it was increased in LSM. Other inflammatory markers, as well as leptin, LIF, follistatin, BDNF, and fasting triacylglycerol were not significantly affected by any of the interventions. CONCLUSION: Besides preventing a modest negative effect of LSM on IL6 and adiponectin level, the combination of LSM and EPA + DHA supplementation could be probably used to improve the functional capacity of adipose tissue in women with overweight.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19017032
- 003
- CZ-PrNML
- 005
- 20210907085922.0
- 007
- ta
- 008
- 190513s2018 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a5259 $2 doi
- 035 __
- $a (PubMed)30660136
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Sedláček, Pavel $u Department of Public Health and Preventive Medicine, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $7 _AN067947
- 245 10
- $a Effect of n-3 fatty acids supplementation during life style modification in women with overweight / $c P. Sedláček, I. Plavinová, J. Langmajerová, J. Dvořáková, J. Novák, L. Trefil, L. Müller, P. Buňatová, V. Zeman, D. Müllerová
- 520 9_
- $a OBJECTIVE: The marine n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exert numerous beneficial effects on health, but their potency to defend against development of peripheral insulin resistance of healthy person with overweight remains poorly characterized. We aimed to evaluate the effect of a combination intervention using EPA + DHA and the lifestyle modification (LSM) in women with overweight. METHOD: In a parallel-group, three-arm, randomized trial (UMIN Clinical Trials Registry - R000031131), 34 women were assigned to a 12-week-intervention using corn oil (1.5 g/day; placebo); LSM and corn oil (1.5 g/day; LSM); or LSM and EPA + DHA concentrate (1.5 g/day, containing ~ 0.6 g EPA + DHA; LSM & n-3). At baseline and after intervention, anthropometric measurements including bioelectrical impedance analysis, spiroergometry, 24-hours dietary recall, and various metabolic markers, adiponectin and cytokines were evaluated in serum using standard procedures. Data from 29 women were used for the final evaluation. Wilcoxon two-sided rank-sum test was used to inspect the differences between LSM and LSM & n-3, and placebo groups, with a p-value of ≤ 0.05. All computations were performed with MATLAB Statistics Toolbox. RESULTS: In comparison with placebo, LSM and LSM & n-3 decreased body weight, waist circumference, and body fat, and increased VO2max/kg. LSM & n-3 increased adiponectin levels in comparison to LSM. Fasting insulin, IL8, and cholesterol were decreased by LSM, but were unchanged by LSM & n-3. IL6 was not affected in LSM & n-3, while it was increased in LSM. Other inflammatory markers, as well as leptin, LIF, follistatin, BDNF, and fasting triacylglycerol were not significantly affected by any of the interventions. CONCLUSION: Besides preventing a modest negative effect of LSM on IL6 and adiponectin level, the combination of LSM and EPA + DHA supplementation could be probably used to improve the functional capacity of adipose tissue in women with overweight.
- 650 12
- $a potravní doplňky $7 D019587
- 650 _2
- $a kyseliny dokosahexaenové $x terapeutické užití $7 D004281
- 650 _2
- $a kyselina eikosapentaenová $x terapeutické užití $7 D015118
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a zdravý životní styl $7 D000070497
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nadváha $x terapie $7 D050177
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Plavinová, Iveta, $u Department of Public Health and Preventive Medicine, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $d 1987- $7 xx0263837
- 700 1_
- $a Langmajerová, Jana, $u Department of Public Health and Preventive Medicine, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $d 1967- $7 xx0121828
- 700 1_
- $a Dvořáková, Jana $u Department of Public Health and Preventive Medicine, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $7 _AN070612
- 700 1_
- $a Novák, Jaroslav, $u Department of Physical Education, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $d 1941- $7 nlk20020105693
- 700 1_
- $a Trefil, Ladislav $u Department of Clinical Biochemistry and Haematology, Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic $7 xx0099653
- 700 1_
- $a Müller, Luděk, $u European Centre of Excellence, New Technologies for the Information Society, University of West Bohemia, Pilsen, Czech Republic $d 1961- $7 stk2007383203
- 700 1_
- $a Buňatová, Petra $u Department of Psychiatry, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Zeman, Václav, $u Department of Physical Education, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $d 1940-2020 $7 jn20000402735
- 700 1_
- $a Müllerová, Dana, $u Department of Public Health and Preventive Medicine, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic $d 1962- $7 xx0011940
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 26, č. 4 (2018), s. 265-271
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30660136 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y 4 $z 0
- 990 __
- $a 20190513 $b ABA008
- 991 __
- $a 20210907085918 $b ABA008
- 999 __
- $a ok $b bmc $g 1408680 $s 1055973
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 26 $c 4 $d 265-271 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK118 $a Pubmed-20190513